Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
Sodium aurothiomalate
MYOCRISIN(R) 1 MYOCRISIN(R) _Sodium aurothiomalate_ CONSUMER MEDICINE INFORMATION (CMI) WHAT IS IN THIS LEAFLET This leaflet answers some common questions about Myocrisin. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you being given this medicine against the benefits they expect it will have for you. IF YOU HAVE ANY CONCERNS ABOUT BEING GIVEN THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH THE MEDICINE. You may need to read it again. WHAT MYOCRISIN IS USED FOR Myocrisin is a type of medicine used to help treat rheumatoid arthritis and Still's disease (a form of arthritis in children). Myocrisin helps to reduce the inflammation which can occur with arthritis. Your doctor, however, may prescribe Myocrisin for another purpose. ASK YOUR DOCTOR OR PHARMACIST IF YOU HAVE ANY QUESTIONS ABOUT WHY IT HAS BEEN PRESCRIBED FOR YOU. This medicine is only available with a doctor's prescription. BEFORE YOU ARE GIVEN IT _WHEN YOU MUST NOT BE GIVEN_ _IT_ DO NOT RECEIVE MYOCRISIN IF YOU HAVE: * LIVER DISEASE * KIDNEY DISEASE * DIABETES * BLOOD DISORDERS OR A HISTORY OF BLOOD DISORDERS * ANY SERIOUS SKIN DISORDERS * ARE PREGNANT OR PLAN TO BECOME PREGNANT DO NOT RECEIVE MYOCRISIN IF YOU ARE ALLERGIC TO IT OR ANY OF THE INGREDIENTS LISTED AT THE END OF THIS LEAFLET. Some symptoms of an allergic reaction include skin rash, itching, shortness of breath or swelling of the face, lips or tongue, which may cause difficulty in swallowing or breathing. DO NOT USE MYOCRISIN IF THE SOLUTION HAS DARKENED IN COLOUR. Any solution darker than a pale yellow should not be used. DO NOT RECEIVE IT IF YOU ARE PREGNANT OR INTEND TO BECOME PREGNANT. It may affect your developing baby if you are given it during pregnancy. DO NOT RECEIVE IT IF YOU ARE BREASTFEEDING O Read the complete document
_Myocrisin PI _ _ _ _#7557v4.0 Page _ 1_ _ PRODUCT INFORMATION MYOCRISIN ® NAME OF THE MEDICINE NON-PROPRIETARY NAME Sodium aurothiomalate DESCRIPTION Each ampoule of MYOCRISIN solution for injection contains 10mg, 20mg or 50mg of sodium aurothiomalate and phenylmercuric nitrate and water for injections. PHARMACOLOGY SITE AND MODE OF ACTION In rheumatoid arthritis, MYOCRISIN appears to suppress the disease processes in two ways. Firstly it penetrates into the joint cavity and affects the lysosomal membranes. Secondly, it binds to plasma proteins, including IgG, the rheumatoid factor and the immune complex so that when the lysosomes ingest immune complex the gold is absorbed with it and inactivates lysosomal enzymes within the cell. INDICATIONS Adjunctive treatment of rheumatoid arthritis that is not adequately controlled by other anti- inflammatory agents and conservative measures. In chronic, advanced cases of rheumatoid arthritis, gold therapy is less valuable. Still's disease. CONTRAINDICATIONS Hypersensitivity to any component of this product. Patients with gross renal or hepatic disease, diabetes, marked toxaemia, a history of blood dyscrasias or exfoliative dermatitis. Use in Pregnancy is contraindicated (See Precautions). PRECAUTIONS Every candidate for gold therapy should be investigated fully to prevent the administration of gold to those with gross renal or hepatic defects, diabetes, marked toxaemia, a history of blood dyscrasias or dermatitis. Before starting treatment, and again before each injection, the urine should be tested for protein, the skin inspected for rashes, and a full blood count performed, with a numerical platelet count (not an estimation). The availability, whenever possible, of the results of blood counts before the next injection is a useful aid in minimising toxic reactions. Minimum values below which gold should not be given until the count has been repeated and there is r Read the complete document